Drug Recall


HPS Pharmacies wish to advise that Apotex, in consultation with the Therapeutic Goods Administration (TGA), has given notice of a drug recall of APO-Perindopril Arginine as follows:

APO-Perindopril Arginine 2.5mg
Perindopril arginine 2.5mg
ARTG 184808

APO-Perindopril Arginine 5mg
Perindopril arginine 5mg
ARTG 184806

APO-Perindopril Arginine 10mg
Perindopril arginine 10mg
ARTG 184812

The only affected batches are as follows:



Expiry Date

APO-Perindopril Arginine 2.5mg


February 2020

APO-Perindopril Arginine 5mg


March 2020

APO-Perindopril Arginine 10mg


May 2019

This recall has been initiated as some bottles from these batches may be contaminated with dark particles of silica. It is presumed that these particles have been released from the desiccant cylinder placed inside the bottle to protect the contents from moisture. The particles may appear as specks or as a dust that discolours the tablets and the inside of the bottle. This potential contamination is classified as a quality defect and is not considered to impact the safety or efficacy of the product.

Please inspect your stock and quarantine any affected batches. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on 1800 629 921.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates